Abstract:The introduction of lipid-formula Amphotericin B, Voriconazole, and Echinocandins, including Caspofungin and Micafungin, reflect the trend that the antifungal drugs are being developed along to a direction with high effect, broad spectrum, and low toxicity. These drugs undoubtedly provide novel useful approaches to the treatment of invasive fungal infections. Compared to the traditional antifungal drug, such as amphotericin B and Fluconazole, these drugs have the character of good effect and low adverse effect, which will be very important to prophylaxis and treatment for systemic fungal infections. The information concerning for these issues is being reviewed in this paper.
